Back to Search
Start Over
A smart metal-polyphenol-DNAzyme nanoplatform for gene-chemodynamic synergistic tumor therapy.
- Source :
-
Acta biomaterialia [Acta Biomater] 2023 Sep 01; Vol. 167, pp. 564-573. Date of Electronic Publication: 2023 May 28. - Publication Year :
- 2023
-
Abstract
- DNAzyme-based gene regulation shows great potential for the therapy of many cancers. However, ineffective delivery and insufficient cofactor supply pose challenges for potent gene therapy. In this study, we constructed a smart metal-polyphenol-DNAzyme nanoplatform (TA-Mn@Dz NPs) with intrinsic stability, effective delivery, and cofactor self-supply ability for gene-chemodynamic synergistic tumor therapy. Tannic acid, a plant-derived polyphenol, acts as an intermediate structural unit to mediate the assembly of Mn <superscript>2+</superscript> /DNAzyme and tumor acid environment-responsive nanocarriers. Intracellularly, the acidic environment triggers the decomposition of TA-Mn@Dz NPs to release DNAzyme and Mn <superscript>2+</superscript> . The Mn <superscript>2+</superscript> ion not only boosts the catalytic cleavage of surviving mRNA for effective gene therapy but also activates chemodynamic therapy (CDT), generating highly toxic ·OH from endogenous H <subscript>2</subscript> O <subscript>2</subscript> . When tail intravenously injected into MCF-7 tumor-bearing mice, the TA-Mn@Dz NPs display desirable synergistic gene-chemodynamic antitumor effects, paving the way for developing DNAzyme-based multifunctional theranostic platforms for biomedical applications. STATEMENT OF SIGNIFICANCE: 1. A smart metal-polyphenol-DNAzyme nanoplatform was constructed for gene-chemodynamic synergistic tumor therapy. 2. Tannic acid act as intermediate structural units to mediate the assembly of Mn <superscript>2+</superscript> /DNAzyme and tumor acid environment-responsive nanocarriers. 3. The Mn <superscript>2+</superscript> -ion could not only boost the catalytic cleavage of surviving mRNA for effective gene therapy, but also catalyze endogenous H <subscript>2</subscript> O <subscript>2</subscript> to form cytotoxic hydroxyl radicals for chemodynamic therapy. 4. Our work paves an extremely simple way to integrate gene therapy with CDT for the dual-catalytic tumor treatment.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2023 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1878-7568
- Volume :
- 167
- Database :
- MEDLINE
- Journal :
- Acta biomaterialia
- Publication Type :
- Academic Journal
- Accession number :
- 37253417
- Full Text :
- https://doi.org/10.1016/j.actbio.2023.05.042